524 related articles for article (PubMed ID: 18390575)
1. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.
Harrison SA; Oliver D; Arnold HL; Gogia S; Neuschwander-Tetri BA
Gut; 2008 Oct; 57(10):1441-7. PubMed ID: 18390575
[TBL] [Abstract][Full Text] [Related]
2. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
[TBL] [Abstract][Full Text] [Related]
3. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
4. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
7. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.
Wong VW; Wong GL; Chim AM; Tse AM; Tsang SW; Hui AY; Choi PC; Chan AW; So WY; Chan FK; Sung JJ; Chan HL
Am J Gastroenterol; 2008 Jul; 103(7):1682-8. PubMed ID: 18616651
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
9. Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.
Tsang SW; Ng WF; Wu BP; Chow DA; Li ET; Wong TC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):116-21. PubMed ID: 16706822
[TBL] [Abstract][Full Text] [Related]
10. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
Shieh K; Gilchrist JM; Promrat K
Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and waist circumference in non-alcoholic fatty liver disease.
Rocha R; Cotrim HP; Carvalho FM; Siqueira AC; Braga H; Freitas LA
J Hum Nutr Diet; 2005 Oct; 18(5):365-70. PubMed ID: 16150132
[TBL] [Abstract][Full Text] [Related]
13. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.
Hossain N; Afendy A; Stepanova M; Nader F; Srishord M; Rafiq N; Goodman Z; Younossi Z
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1224-9, 1229.e1-2. PubMed ID: 19559819
[TBL] [Abstract][Full Text] [Related]
14. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
[TBL] [Abstract][Full Text] [Related]
15. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
Palekar NA; Naus R; Larson SP; Ward J; Harrison SA
Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
[TBL] [Abstract][Full Text] [Related]
16. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
[TBL] [Abstract][Full Text] [Related]
17. Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension.
Sorrentino P; Terracciano L; D'Angelo S; Ferbo U; Bracigliano A; Vecchione R
Am J Gastroenterol; 2010 Feb; 105(2):336-44. PubMed ID: 19861959
[TBL] [Abstract][Full Text] [Related]
18. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
20. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
